Shreekrishna Biotech Ltd. - Research Center
505592 SHKRISHNAB Group (XT) BSE data
Results
Statement
More
Mar ' 17 |
Mar ' 16 |
Mar ' 15 |
Mar ' 14 |
Mar ' 13 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
Secured loans
Unsecured loans
Total
10.20 |
10.21 |
20.85 |
20.85 |
2.25 |
Gross block
Less : revaluation reserve
Less : accumulated depreciation
Net block
Capital work-in-progress
Investments
Current assets, loans & advances
20.90 |
20.91 |
20.92 |
21.72 |
2.32 |
Less : current liabilities & provisions
10.77 |
10.76 |
0.13 |
0.13 |
0.13 |
Total net current assets
10.13 |
10.15 |
20.79 |
21.59 |
2.18 |
Miscellaneous expenses not written
Total
10.20 |
10.21 |
20.85 |
21.65 |
2.25 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
98.52 |
98.52 |
98.52 |
98.52 |
18.52 |